乌司奴单抗-话题@MedSci

#乌司奴单抗#

5篇内容 | 2021人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2217484, encodeId=cc70221e484a6, content=<a href='/topic/show?id=d15b546e9f7' target=_blank style='color:#2F92EE;'>#托法替布#</a> <a href='/topic/show?id=b92d233416b' target=_blank style='color:#2F92EE;'>#乌司奴单抗#</a> <a href='/topic/show?id=2f3911e2522e' target=_blank style='color:#2F92EE;'>#难治性溃疡性结肠炎#</a>, objectTitle=UEGJ：托法替布和乌司奴单抗作为难治性溃疡性结肠炎三线治疗的比较, objectType=article, longId=836826, objectId=c261836826d3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240717/1721184302415_92910.jpg, objectUrl=/article/show_article.do?id=c261836826d3, replyNumber=0, likeNumber=40, createdTime=2024-07-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c261836826d3, moduleTitle=UEGJ：托法替布和乌司奴单抗作为难治性溃疡性结肠炎三线治疗的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c261836826d3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2208395, encodeId=077722083952d, content=<a href='/topic/show?id=05c46645ec3' target=_blank style='color:#2F92EE;'>#溃疡性结肠炎#</a> <a href='/topic/show?id=b92d233416b' target=_blank style='color:#2F92EE;'>#乌司奴单抗#</a>, objectTitle=AJG：乌司奴单抗治疗溃疡性结肠炎4年的疗效和安全性, objectType=article, longId=828785, objectId=96af828e851f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240605/1717552199480_92910.png, objectUrl=/article/show_article.do?id=96af828e851f, replyNumber=0, likeNumber=155, createdTime=2024-06-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=96af828e851f, moduleTitle=AJG：乌司奴单抗治疗溃疡性结肠炎4年的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96af828e851f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2189298, encodeId=50db2189298c7, content=<a href='/topic/show?id=05c46645ec3' target=_blank style='color:#2F92EE;'>#溃疡性结肠炎#</a> <a href='/topic/show?id=b92d233416b' target=_blank style='color:#2F92EE;'>#乌司奴单抗#</a> <a href='/topic/show?id=68b311150446' target=_blank style='color:#2F92EE;'>#ECCO 2024#</a>, objectTitle=ECCO 2024：乌司奴单抗治疗溃疡性结肠炎的短期和长期有效性与安全性：ULISES 研究, objectType=article, longId=814758, objectId=83a4814e581e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240225/1708856569560_8624274.png, objectUrl=/article/show_article.do?id=83a4814e581e, replyNumber=0, likeNumber=97, createdTime=2024-02-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=83a4814e581e, moduleTitle=ECCO 2024：乌司奴单抗治疗溃疡性结肠炎的短期和长期有效性与安全性：ULISES 研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83a4814e581e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2189166, encodeId=9beb21891663b, content=<a href='/topic/show?id=b92d233416b' target=_blank style='color:#2F92EE;'>#乌司奴单抗#</a> <a href='/topic/show?id=4a291193275' target=_blank style='color:#2F92EE;'>#Mirikizumab#</a> <a href='/topic/show?id=68b311150446' target=_blank style='color:#2F92EE;'>#ECCO 2024#</a>, objectTitle=ECCO 2024：Mirikizumab与乌司奴单抗对中重度克罗恩病患者的疗效比较, objectType=article, longId=814619, objectId=5e32814619ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240224/1708774713658_8624274.png, objectUrl=/article/show_article.do?id=5e32814619ad, replyNumber=0, likeNumber=78, createdTime=2024-02-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5e32814619ad, moduleTitle=ECCO 2024：Mirikizumab与乌司奴单抗对中重度克罗恩病患者的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e32814619ad)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1221236, encodeId=2439122123618, content=<a href='/topic/show?id=b92d233416b' target=_blank style='color:#2F92EE;'>#乌司奴单抗#</a><a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>, objectTitle=JAMA：乌司奴单抗停用后阿巴西普共刺激阻断对中重度斑块状银屑病患者的影响PAUSE 随机临床试验, objectType=article, longId=218928, objectId=8cc2218928d6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20211020/1634698656525_5570441.jpg, objectUrl=/article/show_article.do?id=8cc2218928d6, replyNumber=0, likeNumber=0, createdTime=2022-05-20, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cc2218928d6, moduleTitle=JAMA：乌司奴单抗停用后阿巴西普共刺激阻断对中重度斑块状银屑病患者的影响PAUSE 随机临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cc2218928d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1221234, encodeId=0b0d122123473, content=<a href='/topic/show?id=b92d233416b' target=_blank style='color:#2F92EE;'>#乌司奴单抗#</a>与<a href='/topic/show?id=05c46645ec3' target=_blank style='color:#2F92EE;'>#溃疡性结肠炎#</a>, objectTitle=AP&T: 乌司奴单抗维持治疗对溃疡性结肠炎患者的有效性和安全性分析, objectType=article, longId=217118, objectId=d9f521e118d3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021914/1631609605299_2071404.jpg, objectUrl=/article/show_article.do?id=d9f521e118d3, replyNumber=0, likeNumber=133, createdTime=2022-05-20, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9f521e118d3, moduleTitle=AP&T: 乌司奴单抗维持治疗对溃疡性结肠炎患者的有效性和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9f521e118d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1221232, encodeId=ade31221232c5, content=<a href='/topic/show?id=b92d233416b' target=_blank style='color:#2F92EE;'>#乌司奴单抗#</a>与<a href='/topic/show?id=2e6e6e0315d' target=_blank style='color:#2F92EE;'>#炎症性肠病#</a>, objectTitle=J Gastroenterology：黏膜 IL23A 表达水平可预测炎症性肠病对乌司奴单抗的反应, objectType=article, longId=218083, objectId=3a422180833c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021103/1633247221185_2071404.jpeg, objectUrl=/article/show_article.do?id=3a422180833c, replyNumber=0, likeNumber=124, createdTime=2022-05-20, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a422180833c, moduleTitle=J Gastroenterology：黏膜 IL23A 表达水平可预测炎症性肠病对乌司奴单抗的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a422180833c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1221231, encodeId=6e02122123146, content=<a href='/topic/show?id=b92d233416b' target=_blank style='color:#2F92EE;'>#乌司奴单抗#</a><a href='/topic/show?id=fde528896bd' target=_blank style='color:#2F92EE;'>#克罗恩病#</a>, objectTitle=THER ADV GASTROENTER：乌司奴单抗对难治性克罗恩病患者的疗效分析, objectType=article, longId=299690, objectId=88f0299690d0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2022226/1645805130044_5579292.jpg, objectUrl=/article/show_article.do?id=88f0299690d0, replyNumber=0, likeNumber=145, createdTime=2022-05-20, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88f0299690d0, moduleTitle=THER ADV GASTROENTER：乌司奴单抗对难治性克罗恩病患者的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88f0299690d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1221228, encodeId=bbbb122122828, content=<a href='/topic/show?id=d945e1670d9' target=_blank style='color:#2F92EE;'>#白塞病#</a><a href='/topic/show?id=b92d233416b' target=_blank style='color:#2F92EE;'>#乌司奴单抗#</a>, objectTitle=Arthritis Rheumatol：乌司奴单抗治疗白塞病的长期结局, objectType=article, longId=164936, objectId=e43d16493648, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201904/20190424122816253.jpg, objectUrl=/article/show_article.do?id=e43d16493648, replyNumber=0, likeNumber=119, createdTime=2022-05-20, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e43d16493648, moduleTitle=Arthritis Rheumatol：乌司奴单抗治疗白塞病的长期结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e43d16493648)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

乌司奴单抗

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#托法替布# #乌司奴单抗# #难治性溃疡性结肠炎#

UEGJ：托法替布和乌司奴单抗作为难治性溃疡性结肠炎三线治疗的比较

2024-07-30发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#溃疡性结肠炎# #乌司奴单抗#

AJG：乌司奴单抗治疗溃疡性结肠炎4年的疗效和安全性

2024-06-05发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#溃疡性结肠炎# #乌司奴单抗# #ECCO 2024#

ECCO 2024：乌司奴单抗治疗溃疡性结肠炎的短期和长期有效性与安全性：ULISES 研究

2024-02-25发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#乌司奴单抗# #Mirikizumab# #ECCO 2024#

ECCO 2024：Mirikizumab与乌司奴单抗对中重度克罗恩病患者的疗效比较

2024-02-24发表于上海

赛华佗 (审核中...)

前往app查看评论内容

#乌司奴单抗##银屑病#

JAMA：乌司奴单抗停用后阿巴西普共刺激阻断对中重度斑块状银屑病患者的影响PAUSE 随机临床试验

2022-05-20

赛华佗 (审核中...)

前往app查看评论内容

#乌司奴单抗#与#溃疡性结肠炎#

AP&T: 乌司奴单抗维持治疗对溃疡性结肠炎患者的有效性和安全性分析

2022-05-20

赛华佗 (审核中...)

前往app查看评论内容

#乌司奴单抗#与#炎症性肠病#

J Gastroenterology：黏膜 IL23A 表达水平可预测炎症性肠病对乌司奴单抗的反应

2022-05-20

赛华佗 (审核中...)

前往app查看评论内容

#乌司奴单抗##克罗恩病#

THER ADV GASTROENTER：乌司奴单抗对难治性克罗恩病患者的疗效分析

2022-05-20

赛华佗 (审核中...)

前往app查看评论内容

#白塞病##乌司奴单抗#

Arthritis Rheumatol：乌司奴单抗治疗白塞病的长期结局

2022-05-20

科室
- - 订阅+
  - 更多科室
工具
服务